Chung-Bao Hsieh
Overview
Explore the profile of Chung-Bao Hsieh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
115
Citations
1049
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mao S, Wang C, Liu C, Hsieh C, Pei D, Chu T, et al.
Endocr J
. 2025 Feb;
PMID: 39894511
Insulin resistance (IR) is the core for type 2 diabetes and metabolic syndrome. The homeostasis assessment model is a straightforward and practical tool for quantifying insulin resistance (HOMA-IR). Multiple adaptive...
2.
Wu Y, Chiao C, Chuang P, Hsieh C, Ko C, Ko C, et al.
Int J Med Sci
. 2024 Sep;
21(12):2348-2364.
PMID: 39310264
Recent advancements have elucidated the multifaceted roles of the Schlafen (SLFN) family, including SLFN5, SLFN11, SLFN12, SLFN13, and SLFN14, which are implicated in immunological responses. However, little is known about...
3.
Liu C, Ho Y, Lee W, Huang C, Lee Y, Hsieh C, et al.
Environ Toxicol
. 2024 Jun;
39(11):4844-4858.
PMID: 38884142
Environmental antineoplastics such as sorafenib may pose a risk to humans through water recycling, and the increased risk of cardiotoxicity is a clinical issue in sorafenib users. Thus, developing strategies...
4.
Liu C, Chang C, Chen I, Lin F, Tzou S, Hsieh C, et al.
Diagnostics (Basel)
. 2024 May;
14(10).
PMID: 38786280
The identification of risk factors for future prediabetes in young men remains largely unexamined. This study enrolled 6247 young ethnic Chinese men with normal fasting plasma glucose at the baseline...
5.
Chiu S, Lin H, Feng A, Lo C, Hsieh C, Chen P, et al.
Eur J Radiol
. 2024 Jan;
170:111266.
PMID: 38185027
Purpose: To analyze the safety of combination treatment comprising drug-eluting bead transarterial chemoembolization (DEB-TACE) and immune checkpoint inhibitors (ICIs) in hepatocellular carcinoma (HCC). Method: In total, 208 HCC patients receiving...
6.
Liu W, Hsieh P, Lin C, Fang W, Wang C, Tsai C, et al.
Can J Cardiol
. 2023 Dec;
40(7):1310-1321.
PMID: 38092190
Background: The burden of asymptomatic left ventricular dysfunction (LVD) is greater than that of heart failure; however, a cost-effective tool for asymptomatic LVD screening has not been well validated. We...
7.
Fan H, Hsieh C, Kuo S, Chen T
World J Gastrointest Surg
. 2022 Oct;
14(9):930-939.
PMID: 36185566
Background: Splenectomy has previously been found to increase the risk of cancer development, including lung, non-melanoma skin cancer, leukemia, lymphoma, Hodgkin's lymphoma, and ovarian cancer. The risk of cancer development...
8.
Wu Y, Wang W, Chan T, Chiu Y, Lin H, Chang Y, et al.
JMIR Serious Games
. 2022 Mar;
10(1):e35040.
PMID: 35315780
Background: The COVID-19 outbreak has not only changed the lifestyles of people globally but has also resulted in other challenges, such as the requirement of self-isolation and distance learning. Moreover,...
9.
Lee T, Liao G, Fan H, Hsieh C, Chen T, Chan D
J Oncol
. 2021 Nov;
2021:5459432.
PMID: 34804160
Background: Patients with advanced gastric cancer (AGC) with peritoneal carcinomatosis (PC) usually have poor outcomes and high mortality risk, even with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). This...
10.
Shiu T, Lin H, Shih Y, Feng A, Huang H, Huang T, et al.
Life Sci
. 2021 Jun;
284:119708.
PMID: 34153299
Aims: Hepatocellular carcinoma (HCC) is a primary malignancy of the hepatocyte. Interleukin enhancer binding factor 2 (ILF2) plays a role in the development of HCC. However, the regulatory mechanisms of...